TABLE 1.
Patient Characteristics (N = 80)
Male, % | 42 (53%) |
Age at first symptom, yrs | 11.0 (6.0-13.0) |
Age at diagnosis, yrs | 11.0 (7.4-14.0) |
Follow-up, yrs | 6.4 (2.2-10.0) |
Proband | 66 (83) |
Family history of CPVT | 19 (24) |
History of cardiac arrest | 29 (36) |
Positive genetic testing | 49 (80) |
RyR2 | 45 (92) |
CASQ2 | 2 (4) |
KCNJ2 | 2 (4) |
Antiarrhythmic | |
β anti-adrenergic blocker | 78 (98) |
Flecainide | 15 (19) |
Calcium channel blocker | 12 (15) |
ICD (n = 49) | |
Age at implantation, yrs | 13.5 (9.3-16.7) |
ICD follow up | 9.0 (6.0-12.1) |
Dual chamber | 26 (53) |
Left cardiac sympathetic denervation | 15 (19) |
Deaths | 3 (4) |
Values are n (%) or median (interquartile range).
CPVT = catechotaminergic polymorphic ventricular tachycardia; ICD = implantable cardioverter defibrillator.